(Q39953556)

15 September 2017

title

Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India (English)

1 reference

15 September 2017

0 references

P Majhi

1

1 reference

15 September 2017

R Bagga

series ordinal

2

1 reference

15 September 2017

J Kalra

series ordinal

3

1 reference

15 September 2017

M Sharma

series ordinal

4

1 reference

15 September 2017

publication date

1 August 2009

1 reference

Journal of Obstetrics and Gynaecology

15 September 2017

published in

1 reference

15 September 2017

volume

29

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

493-498

1 reference

Preterm birth prevention: where are we?

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Progestogen administration in pregnancy may prevent preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Risk factors for preterm labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Oral micronized progesterone for prevention of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

Prevention of premature labor by 17α-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01443610902980878

10.1080/01443610902980878

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference